Psyence Group Announces Partnership With Base Pair Health And Strengthens Management Team

Red Light Holland Engages Former Canadian Special Operations Forces Officer, Glenn Cowan, Founder of One 9 Investments, to Advisory Board

Psyence Group Launches its Functional Mushroom Brand, “GOODMIND” Makes Board Changes

MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury

Regulatory Approvals Place Numinus Lab at the Forefront of Global Psychedelics Research

PsyBio Therapeutics Announces Retention of Market Maker

MagicMed Industries Announces Collaboration with Artificial Intelligence Thought Leaders and the Launch of PsyAI

Tryp Therapeutics Announces Application to List on OTCQB

Core One Labs’ Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvão to License Bio Synthesized Psilocybin in Brazil

Cybin Inc. Announces Uplisting to OTCQB Venture Market

Entheon Biomedical Announces Nancy Maher, Special Advisor of Data Science and Regulatory Affairs

Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board

MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company's Clinical Research

Novamind Expands Leadership Team, Accelerating M&A

Nova Mentis Launches Autism Microbiome Study in the United States

Red Light Holland's iMicro Digital Care App Launches Virtual Telecounseling with a Membership Program Led by Certified Therapist and Microdosing Expert